Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 129.950 | 129.990 | 0.040 |
Bonds | 4.670 | 4.670 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.574 | 14.489 |
Price to Book | 3.201 | 2.004 |
Price to Sales | 2.200 | 1.302 |
Price to Cash Flow | 15.023 | 8.994 |
Dividend Yield | 2.468 | 3.331 |
5 Years Earnings Growth | 8.745 | 11.983 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 19.090 | 13.797 |
Consumer Cyclical | 18.220 | 12.860 |
Basic Materials | 14.870 | 8.648 |
Consumer Defensive | 12.460 | 9.370 |
Technology | 10.630 | 11.804 |
Financial Services | 10.400 | 14.583 |
Communication Services | 8.220 | 7.133 |
Industrials | 4.910 | 19.870 |
Utilities | 1.200 | 2.738 |
Number of long holdings: 59
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amundi | FR0004125920 | 8.36 | 66.35 | -0.15% | |
Danone (Fp*)- Cfd | - | 6.76 | - | - | |
Elis Sa (Fp*)- Cfd | - | 5.76 | - | - | |
Bureau Veritas Sa (Fp*)- Cfd | - | 5.59 | - | - | |
Hermes International | FR0000052292 | 5.00 | 2,681.00 | +0.71% | |
Hermes International (Fp*)- Cfd | - | 4.82 | - | - | |
BKO 2 12/10/26 Corp | - | 4.67 | - | - | |
Eurofins Scientific | FR0014000MR3 | 4.43 | 49.43 | -1.77% | |
IMCD NV | NL0010801007 | 4.41 | 150.20 | -0.23% | |
Roche Holding Participation | CH0012032048 | 4.38 | 280.80 | +0.18% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1371438018 | 20.33M | 2.92 | - | - | ||
LU1371436152 | 2M | -4.25 | - | - | ||
LU1842610906 | 2.05M | -5.56 | -2.43 | - | ||
LU1371437127 | 2M | -4.23 | -0.98 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review